ArticleFrontiers in public health2025
Global burden of alcoholic cardiomyopathy in middle-aged men (1990-2021) and projections to 2050: a systematic analysis of the Global Burden of Disease 2021 data.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Alcoholic cardiomyopathy (ACM) is a severe cardiovascular condition caused by chronic excessive alcohol consumption, leading to heart failure, increased morbidity, and mortality. This study aimed to comprehensively analyze the global burden of ACM among middle-aged males from 1990 to 2021 using the Global Burden of Disease (GBD) data. Additionally, we projected future trends until 2050 using time-series forecasting models. Methods: We extracted ACM-related mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) from the GBD 2021 dataset across 204 countries and territories. Temporal trends were assessed using estimated annual percentage change (EAPC). Regional clustering was performed using hierarchical analysis. Future projections were estimated using Autoregressive Integrated Moving Average (ARIMA) and Exponential Smoothing (ES) models. Results: In 2021, ACM caused 51,494 deaths (95% UI: 44,031-56,451), with an age-standardized death rate of 1.24 per 100,000 (95% UI: 1.06-1.36). DALYs reached 1,771,812 (95% UI: 1,521,953-1,943,500), with an age-standardized rate of 41.81 per 100,000 (95% UI: 35.97-45.8). The burden was highest in Eastern Europe, Central Asia, and Latin America. Future projections suggest a potential stabilization or gradual decline in ACM burden, though mortality and DALYs remain high in some regions. Conclusion: ACM remains a major global health challenge, particularly in middle-aged males. Regional disparities highlight the need for targeted alcohol control policies and improved cardiovascular healthcare. Strengthened public health interventions are crucial to mitigating ACM-related mortality and disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.